Is Netflix, Inc. (NFLX) a Buy, Sell, or Hold?
NASDAQ : NFLX
Netflix, Inc. — Stock Grades
$68.67 USD
$1.07 (1.58%)
- Volume
- 56.18M
- Average Volume
- 42.64M
- Market Capitalization
- $289.16B
- P/E Ratio
- 21.73
- Dividend Yield
- 0.00%
- Price Target
- $93.00
- Year High
- $126.71
- Year Low
- $65.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.41
NFLX Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-17 | KGI Securities | Outperform | Neutral | Downgrade |
| 2026-07-17 | Goldman Sachs | Buy | Buy | Maintain |
| 2026-07-17 | Bernstein | Outperform | Outperform | Maintain |
| 2026-07-17 | TD Cowen | Buy | Buy | Maintain |
| 2026-07-17 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-07-17 | Wedbush | Outperform | Outperform | Maintain |
| 2026-07-17 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-07-17 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-07-17 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-07-17 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-07-17 | UBS | Buy | Buy | Maintain |
| 2026-07-17 | Rosenblatt | Neutral | Neutral | Maintain |
| 2026-07-17 | Pivotal Research | Hold | Hold | Maintain |
| 2026-07-17 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-07-17 | Guggenheim | Buy | Buy | Maintain |
| 2026-07-17 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-07-15 | Guggenheim | Buy | Buy | Maintain |
| 2026-07-14 | Rosenblatt | Neutral | Neutral | Maintain |
| 2026-07-14 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-07-14 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-07-13 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-07-13 | Keybanc | Overweight | Overweight | Maintain |
| 2026-07-09 | Citigroup | Buy | Buy | Maintain |
| 2026-07-08 | Bernstein | Outperform | Outperform | Maintain |
| 2026-05-18 | B of A Securities | Buy | Buy | Maintain |
| 2026-05-15 | Guggenheim | Buy | Buy | Maintain |
| 2026-04-17 | Keybanc | Overweight | Overweight | Maintain |
| 2026-04-17 | Citizens | Market Perform | Market Perform | Maintain |
| 2026-04-17 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-04-17 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-04-17 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-04-17 | Rosenblatt | Neutral | Neutral | Maintain |
| 2026-04-17 | Guggenheim | Buy | Buy | Maintain |
| 2026-04-17 | Wedbush | Outperform | Outperform | Maintain |
| 2026-04-15 | Citizens | Market Perform | Market Perform | Maintain |
| 2026-04-14 | Guggenheim | Buy | Buy | Maintain |
| 2026-04-14 | Keybanc | Overweight | Overweight | Maintain |
| 2026-04-13 | Wedbush | Outperform | Outperform | Maintain |
| 2026-04-06 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2026-04-06 | Rosenblatt | Neutral | Neutral | Maintain |
| 2026-03-27 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-03-06 | B of A Securities | Buy | Buy | Maintain |
| 2026-03-06 | CFRA | Hold | Buy | Upgrade |
| 2026-03-02 | JP Morgan | Neutral | Overweight | Upgrade |
| 2026-02-27 | Rosenblatt | Neutral | Neutral | Maintain |
| 2026-02-20 | Wedbush | Outperform | Outperform | Maintain |
| 2026-01-27 | Freedom Capital Markets | Hold | Buy | Upgrade |
| 2026-01-27 | Freedom Broker | Hold | Buy | Upgrade |
| 2026-01-22 | Argus Research | Buy | Buy | Maintain |
| 2026-01-21 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-01-21 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-01-21 | Wedbush | Outperform | Outperform | Maintain |
| 2026-01-21 | BMO Capital | Outperform | Outperform | Maintain |
| 2026-01-21 | Rosenblatt | Neutral | Neutral | Maintain |
| 2026-01-21 | Needham | Buy | Buy | Maintain |
| 2026-01-21 | Guggenheim | Buy | Buy | Maintain |
| 2026-01-21 | Deutsche Bank | Hold | Hold | Maintain |
| 2026-01-21 | Pivotal Research | Hold | Hold | Maintain |
| 2026-01-21 | Keybanc | Overweight | Overweight | Maintain |
| 2026-01-21 | TD Cowen | Buy | Buy | Maintain |
| 2026-01-21 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-01-21 | Wolfe Research | Outperform | Outperform | Maintain |
| 2026-01-21 | UBS | Buy | Buy | Maintain |
| 2026-01-21 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-01-21 | Goldman Sachs | Neutral | Neutral | Maintain |
| 2026-01-16 | Keybanc | Overweight | Overweight | Maintain |
| 2026-01-16 | Rosenblatt | Neutral | Neutral | Maintain |
| 2026-01-15 | Wedbush | Outperform | Outperform | Maintain |
| 2026-01-13 | TD Cowen | Buy | Buy | Maintain |
| 2026-01-05 | CFRA | Buy | Hold | Downgrade |